Brief: Cassava Sciences Reports Q1 2023 Financial Results And Operating Updates

Filana Therapeutics

01/05/2023 14:41

May 1 (Reuters) - Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES REPORTS Q1 2023 FINANCIAL RESULTS AND
OPERATING
UPDATES
    * CASSAVA SCIENCES INC - NEW GUIDANCE FOR NET CASH USE IN
FIRST
HALF 2023 IS EXPECTED TO BE $30 TO $40 MILLION

Source text for Eikon:  ID:nGNX9Rw1Dk 
Further company coverage:  SAVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))